Long-term mortality after IPD and bacteremic versus non-bacteremic pneumococcal pneumonia
- PMID: 28262334
- DOI: 10.1016/j.vaccine.2017.02.037
Long-term mortality after IPD and bacteremic versus non-bacteremic pneumococcal pneumonia
Abstract
Background: Short-term mortality after invasive pneumococcal disease (IPD) and pneumococcal pneumonia is high but data on long-term mortality (including the comparison between bacteremic and non-invasive/non-bacteremic pneumococcal pneumonia) within the first years after diagnosis are scarce.
Methods: Adult patients with 'non-pneumonia' IPD and 'invasive pneumonia' (from 2004 to 2012) and with 'bacteremic' vs 'non-invasive/non-bacteremic (NI/NB)' pneumococcal pneumonia (from 2008 to 2012) diagnosed by negative blood culture but a positive urinary antigen test (UAT) were identified in a Dutch hospital. Mortality of patients up to 10years after diagnosis was compared with age- and sex-matched life-expectancy data of the general population. Multivariable Cox regression analysis was used to study predictors for mortality in invasive pneumonia patients and to adjust for confounders comparing mortality between bacteremic and NI/NB/UAT-positive pneumonia patients.
Results: Of 228 invasive pneumonia patients 17% died within 30days and in 30-day survivors cumulative long-term mortality at 1 and 5years were 16% and 39% as compared with 3% and 15% in age- and sex-matched persons. High mortality was largely dependent on pre-existent comorbidities. In invasive pneumonia patients who survived the first 30days, age, male gender, chronic cardiovascular disease, malignancy and PCV7 serotype disease were independent predictors for higher long-term mortality. For bacteremic pneumonia patients (n=128) 30-day mortality was 16% and almost similar to 14% in NI/NB/UAT-positive pneumococcal pneumonia patients (n=170). In 30-day survivors of bacteremic pneumonia (n=108, median age 66years), cumulative mortality at 1 and 3years were 13% and 29% as compared with 18% and 40% in NI/NB/UAT-positive pneumococcal pneumonia patients (n=146, median age 67years) without a significant difference in mortality.
Conclusions: Approximately 40% of all patients, who survived the first 30days after presentation with non-pneumonia IPD and pneumococcal pneumonia died within the following 5years. High long-term mortality was largely dependent on pre-existent comorbidity.
Keywords: Invasive pneumococcal disease; Long-term mortality; Pneumococcal pneumonia; Serotypes; Streptococcus pneumonia.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Similar articles
-
Risk and outcomes of invasive pneumococcal disease in adults with underlying conditions in the post-PCV7 era, The Netherlands.Vaccine. 2016 Jan 12;34(3):334-40. doi: 10.1016/j.vaccine.2015.11.048. Epub 2015 Nov 29. Vaccine. 2016. PMID: 26647289
-
Invasive Disease vs Urinary Antigen-Confirmed Pneumococcal Community-Acquired Pneumonia.Chest. 2017 Jun;151(6):1311-1319. doi: 10.1016/j.chest.2017.01.005. Epub 2017 Jan 16. Chest. 2017. PMID: 28093269
-
Association of serotype with respiratory presentations of pneumococcal infection, Ontario, Canada, 2003-2011.Vaccine. 2016 Feb 3;34(6):846-53. doi: 10.1016/j.vaccine.2015.11.021. Epub 2015 Nov 18. Vaccine. 2016. PMID: 26602266
-
The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review.Adv Ther. 2013 Feb;30(2):127-51. doi: 10.1007/s12325-013-0007-6. Epub 2013 Feb 7. Adv Ther. 2013. PMID: 23397399 Review.
-
[Retrospective and comparative study of pneumococcal bacteremia in patients with chronic hepatopathy].An Med Interna. 1996 Jul;13(7):313-6. An Med Interna. 1996. PMID: 8962974 Review. Spanish.
Cited by
-
Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly.Risk Manag Healthc Policy. 2018 Mar 27;11:55-65. doi: 10.2147/RMHP.S130405. eCollection 2018. Risk Manag Healthc Policy. 2018. PMID: 29636634 Free PMC article. Review.
-
[Pneumococcal vaccination].Internist (Berl). 2021 Aug;62(8):807-815. doi: 10.1007/s00108-021-01100-2. Epub 2021 Jul 12. Internist (Berl). 2021. PMID: 34251467 Free PMC article. Review. German.
-
Invasive pneumococcal disease and long-term outcomes in children: A 20-year population cohort study.Lancet Reg Health Am. 2022 Aug 8;14:100341. doi: 10.1016/j.lana.2022.100341. eCollection 2022 Oct. Lancet Reg Health Am. 2022. PMID: 36777393 Free PMC article.
-
Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States.Expert Rev Vaccines. 2019 Apr;18(4):327-341. doi: 10.1080/14760584.2019.1582337. Epub 2019 Mar 20. Expert Rev Vaccines. 2019. PMID: 30759352 Free PMC article. Review.
-
Streptococcus pneumoniae serotype 3 population structure in the era of conjugate vaccines, 2001-2018.Microb Genom. 2024 Mar;10(3):001196. doi: 10.1099/mgen.0.001196. Microb Genom. 2024. PMID: 38498591 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical